Qingda granule prevents Ang II-induced cardiac hypertrophy via inhibiting NF-κB signaling pathway
Our findings provide further insight into the robust ability of QDG in preventing Ang II-induced cardiac hypertrophy via preventing NF-κB signaling activation and implicate its use in the clinical treatment of hypertension and cardiac hypertrophy.
Authors
- Celiang Wu
- Ruokun Huang
- Evan Ma (ORCID: https://orcid.org/0000-0002-7468-4340)
- Canran Wang (ORCID: https://orcid.org/0000-0003-3297-9041)
- Da Wo (ORCID: https://orcid.org/0000-0002-8577-7729)
- Jun Peng (ORCID: https://orcid.org/0000-0002-1641-6647)
- Dan‐ni Ren (ORCID: https://orcid.org/0000-0002-7431-8156)
- Weidong D. Zhu (ORCID: https://orcid.org/0000-0003-2707-2533)
- Yuhang Gong
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3389/fphar.2025.1603316
- Citations
- 1
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Natural Science Foundation of Fujian Province
- Fujian University of Traditional Chinese Medicine